Rohto Pharmaceutical Co. Ltd Financials

Market Capitalization ¥468.31 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	15.30
Forward PE	12.40
Price to Sales TTM	¥1.52
Price to Book MRQ	¥1.80
Enterprise to Revenue	1.45
Enterprise to EBITDA	8.65

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2024-06-30
Profit Margin	10.05%
Operating Margin	7.92%
Return on Assets TTM	6.26%
Return on Equity TTM	11.94%

Income Statement

Revenue TTM	¥308,625,014,784
Revenue per Share TTM	¥1354.78
Quarterly Revenue Growth	18.70%
Gross Profit TTM	¥174,938,996,736
EBITDA	¥54,853,000,000
Net Income to Common TTM	¥31,005,999,104
Diluted EPS TTM	¥135.46
Quarterly Earnings Growth YoY	29.70%

Balance Sheet

Total Cash MRQ	¥77,160,996,864
Total Cash per Share MRQ	¥341.47
Total Debt MRQ	¥
Total Debt to Equity MRQ	18.50
Current Ratio MRQ	2.30
Book Value per Share MRQ	¥1151.04

Cash Flow

Operating Cash Flow TTM	¥36,916,998,144
Levered Free Cash Flow TTM	¥16,650,500,096

4527 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	225,964,376
Float Shares	205,959,750
Avg 10 Volume	913,720
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	9.82%
% Held by Institutions	37.06%

Stock Price Summary

Beta	-0.42
Fifty Two Week Low	¥1964.50
Fifty Two Week High	¥3688.00
Fifty Two Week Change	-60.31%
Day 50 MA	¥2152.34
Day 200 MA	¥2614.45

Dividends and Splits

Forward Annual Dividend Rate	¥32.00
Forward Annual Dividend Yield	1.55%
Trailing Annual Dividend Rate	¥31.00
Trailing Annual Dividend Yield	1.50%
Payout Ratio	26.58%
Dividend Date
Ex Dividend Date	2025-09-29
Last Split Factor
Last Split Date	2022-12-29